Free beta — full access, free until October 2026. No card, no auto-charge — paid plans are opt-in when they launch.
Company
Impax Laboratories, LLC (0001003642)
Standardized SEC financial data for Impax Laboratories, LLC — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0001003642 · Pharmaceutical Preparations.
Gross margin
40.9%
Operating margin
-48.8%
Net margin
-56.9%
Revenue growth (YoY)
-4.2%
Return on equity
-250.7%
ROIC
-40.1%
Free cash flow
$57.5M
Debt / equity
4.21×
Ratios for fiscal year 2016, standardized from SEC filings.